http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2085657-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9411d0084862dd627c9683b99a3859d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0055
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
filingDate 1969-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1971-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2085657-A1
titleOfInvention New gitoxin derivatives for oral administration
abstract Penta-alkylsulphonyl-gitoxin (I) is prepd. by reaction of gitoxin with alkylsulphonyl chlorides whereby all reactive OH groups of gitoxin are esterified to 0.SO2R. Reaction of gitoxin with alkyl isocyanates produces penta-(N-alkylcarbamoyl)-gitoxin (II) by conversion of reactive OH to O.CONHR. In both cases R=C1-4-alkyl. I and II are used for the treatment of cardiac insufficiencies by oral administration.
priorityDate 1969-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91540

Total number of triples: 17.